I'm not sure, I didn't invest because of HER-Vaxx but clearly you did since you keep bringing it up so why don't you tell me????? I only know the other 3 IP have FDA IND, Fast Track designation, ODD and path to registrational clinical trial which will be attractive to BP but HER-Vaxx didn't???? and I thought it was very good final result for Ph2 clinical trial completion and not excellent.
IMU Price at posting:
3.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)